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Incidental Findings on Brain Imaging in the General Pediatric 
Population
To the Editor: Incidentally discovered findings 
on brain magnetic resonance imaging (MRI) in 
healthy persons pose medical and ethical consid-
erations regarding management.1 The prevalence 
of incidental findings on brain MRI has been 
described in adult populations,2 but less is known 
about incidental findings in children. We report 
the prevalence of incidental findings on brain 
MRI in a large, single-center neuroimaging study 
involving a general pediatric population. From 
April 2013 through November 2015, a total of 
3966 children (mean age, 10.1 years; range, 8.6 to 
11.9) in the population-based Generation R Study 3 
— designed to prospectively identify early envi-
ronmental and genetic influences on normal 
and abnormal growth, development, and health 
during fetal life, childhood, and young adult-
hood — underwent MRI scanning of the brain 
on a single 3-Tesla scanner. Scans were system-
atically reviewed by trained researchers and 
neuroradiologists for the presence of incidental 
findings (Table 1).
At least one incidental finding was present in 
25.6% of the children (95% confidence interval 
[CI], 24.2 to 27.0), although the prevalence of 
findings requiring clinical follow-up was only 
0.43% (95% CI, 0.26 to 0.70). The most common 
findings were cysts of the pineal gland (in 665 
children; 16.8%; 95% CI, 15.6 to 18.0), arach-
noid cysts (in 86; 2.17%; 95% CI, 1.75 to 2.68), 
and developmental venous anomalies (in 63; 
1.59%; 95% CI, 0.12 to 2.04). Among less fre-
quent findings were Chiari I malformations (in 
25 children; 0.63%; 95% CI, 0.42 to 0.94), sub-
ependymal heterotopia (in 19; 0.48%; 95% CI, 
0.30 to 0.76), and partial agenesis of the corpus 
callosum (in 2; 0.05%; 95% CI, 0.01 to 0.20). A 
total of 17 children (0.43%) were referred to a 
pediatric neurologist for clinical imaging and 
follow-up; 7 of these children (0.18%) had sus-
pected primary brain tumors, of whom 2 under-
went neurosurgical treatment, with the diagno-
ses confirmed by histopathological examination. 
The prevalence of asymptomatic brain tumors in 
our population-based cohort was higher than es-
timates from cancer registries, which have shown 
a prevalence in the United States of approximate-
ly 35 in 100,000 (0.04%) among persons younger 
than 20 years of age.4 However, no reliable sta-
tistics are available to estimate the frequency of 
asymptomatic brain tumors among children.5
Our results emphasize the need for careful 
evaluation of incidental findings on brain scans 
of asymptomatic children. In addition, it may be 
prudent to use standardized protocols for man-
aging incidental findings in children, including 
reporting, disclosure to parents, and subsequent 
follow-up when necessary.
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Finding Finding Present Prevalence Clinical Referral Clinical Management
no. of children % (95% CI) no. of children
Normal variations
Cavum septum pellucidum 79 1.99 (1.59–2.49) 0 —
Mega cisterna magna 104 2.62 (2.16–3.18) 0 —
Empty sella configuration 7 0.18 (0.08–0.38) 0 —
Congenital malformations
Chiari I malformation 25 0.63 (0.42–0.94) 1 MRI follow-up
Partial agenesis of the corpus callosum 2 0.05 (0.01–0.20) 2 Neurologic examination
Agenesis of the septum pellucidum 3 0.08 (0.02–0.24) 0 —
Ventriculomegaly 2 0.05 (0.01–0.20) 1 MRI follow-up
Cysts
Arachnoid cyst 86 2.17 (1.75–2.68) —
<3 cm 75 1.89 (1.50–2.38) 0 —
≥3 cm 11 0.28 (0.15–0.51) 2 MRI follow-up
Pineal gland cyst 665 16.8 (15.6–18.0)
<1 cm 652 16.4 (15.3–17.6) 0 —
≥1 cm 13 0.33 (0.18–0.58) 1 Contrast-enhanced MRI, 
lumbar puncture
Porencephalic cyst 3 0.08 (0.02–0.24) 0 —
Intraventricular cyst 7 0.18 (0.08–0.38) 1 MRI follow-up
Vascular anomalies
Developmental venous anomaly 63 1.59 (0.12–2.04) 0 —
Cavernous angioma 7 0.18 (0.08–0.38) 0 —
Capillary telangiectasia 2 0.05 (0.01–0.20) 0 —
Migration disorders
Subependymal gray-matter heterotopia 19 0.48 (0.30–0.76) 0 —
Transmantle dysplasia 1 0.03 (0.01–0.16) 0 —
Focal cortical dysplasia 1 0.03 (0.01–0.16) 0 —
White-matter abnormalities
Focal white-matter hyperintensity 7 0.18 (0.08–0.38) 0 —
Radiologically isolated syndrome 1 0.03 (0.01–0.16) 1 Contrast-enhanced MRI
Neoplasms
Low-grade glioma† 4 0.10 (0.03–0.28) 4 Contrast-enhanced MRI
Dysembryoplastic neuroepithelial tumor† 1 0.03 (0.01–0.16) 1 Contrast-enhanced MRI
Ependymoma‡ 1 0.03 (0.01–0.16) 1 Contrast-enhanced MRI, 
neurosurgery
Craniopharyngioma‡ 1 0.03 (0.01–0.16) 1 Contrast-enhanced MRI, 
neurosurgery
Other: fibrous dysplasia 1 0.03 (0.01–0.16) 1 Computed tomography
*  Children may have more than one incidental finding. A total of 940 children had one incidental finding, 73 had two incidental findings, and 
2 had three incidental findings. CI denotes confidence interval, and MRI magnetic resonance imaging.
†  Radiologic diagnosis was by means of MRI.
‡  The finding was confirmed by means of histopathological analysis.
Table 1. Incidental Findings in the Generation R Study Population (3966 Children).*
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Instantaneous Wave-free Ratio versus Fractional Flow Reserve
To the Editor: Davies et al. (May 11 issue)1 report 
on the DEFINE-FLAIR trial (Functional Lesion 
Assessment of Intermediate Stenosis to Guide 
Revascularisation). In the same issue, Götberg 
et al.2 report on the iFR-SWEDEHEART trial (In-
stantaneous Wave-free Ratio versus Fractional Flow 
Reserve in Patients with Stable Angina Pectoris 
or Acute Coronary Syndrome). The revasculariza-
tion rate was lower in the instantaneous wave-free 
ratio (iFR) group than in the fractional flow re-
serve (FFR) group in both trials (47.5% and 53.4% 
in the DEFINE-FLAIR trial; 53.0% and 56.5% in 
the iFR-SWEDEHEART trial).
In the ADVISE II study (Adenosine Vasodilator 
Independent Stenosis Evaluation II), an iFR cut-
off value of 0.89, as compared with FFR, had a 
specificity of 87.8% and a sensitivity of 73.0%.3 
Conceivably, revascularization of some lesions that 
would be warranted according to an FFR-guided 
strategy would be deferred with an iFR-guided 
strategy. Although an iFR-guided revasculariza-
tion strategy was noninferior to FFR-guided re-
vascularization in the trials reported by Davies 
et al. and Götberg et al., outcomes in patients 
with iFR-guided deferral of revascularization were 
not reported.
In the FAME 2 trial (Fractional Flow Reserve 
Versus Angiography for Multivessel Evaluation 2), 
among patients with an FFR higher than 0.80 in 
all vessels who were enrolled in a registry and 
received the best available medical therapy, the 
rate of major adverse cardiovascular events was 
3%; this rate was lower than that among pa-
tients who were randomly assigned to both the 
medical-therapy and percutaneous coronary inter-
vention (PCI) groups in this trial.4 It would be 
interesting to know whether the patients in the 
DEFINE-FLAIR and iFR-SWEDEHEART trials who 
had an FFR higher than 0.80 or an iFR higher 
than 0.89 and for whom intervention was de-
ferred had similar outcomes. If indeed the clinical 
outcomes were similar, interventional cardiolo-
gists would have more confidence in deferring 
revascularization if the iFR is higher than 0.89, 
and these findings would help to encourage 
transition from a hybrid iFR–FFR approach to a 
pure iFR-guided strategy.5
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